Article feature image

ImmunoPrecise Antibodies Ltd. (IPA) CEO Jennifer Bath on Q4 2021 Results – Earnings Call Transcript

Stock Analysis

ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Q4 2021 Earnings Conference Call July 28, 2021 4:30 PM ET
Company Participants
John Mullaly – LifeSci Advisors
Jennifer Bath – President & Chief Executive Officer
Lisa Helbling – Chief Financial Officer
Conference…

Click here to view the original article.

Tags:
,
Facebook Google+ Twitter Pinterest

Related Posts